Healthcare expenditure on medical and diagnostic laboratories in Belgium has exhibited significant fluctuations over the past decade. From 2013 to 2015, there was notable variability, with values dropping to 16.12 million Euros in 2014 only to escalate to 22.47 million Euros in 2015. A steady increase was observed from 2017 to 2021, peaking at 54.66 million Euros in 2021. However, from 2022 onward, a decline was noted, culminating at 32.64 million Euros in 2023.
Year-on-year variations indicated considerable volatility, including a sharp increase of 64.67% by 2018 and a major decrease of 39.99% in 2022. The compound annual growth rate (CAGR) reflected these shifts, peaking at 23.22% in 2019 and dropping to -6.86% in 2023.
Looking ahead, forecasts suggest a period of stabilization with slight declines. From 2024 to 2028, expenditures are expected to level off around 32 million Euros, with a minor -0.19% CAGR over the next five years.
Future trends to watch for include potential impacts from technological advancements in diagnostics and healthcare policy changes, which could influence expenditure levels. It is also crucial to monitor the broader economic environment, which may affect funding and investment in healthcare infrastructure.
